When was Dianox founded?

Dianox was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is Dianox located?

Dianox is headquartered in Copenhagen, Denmark.

Which legal entities is Dianox associated with?

Dianox is associated with Dianox ApS.

How many employees does Dianox have?

As of Apr 30, 2026, the latest employee count at Dianox is 10.

Is Dianox a funded company?

Dianox is a funded company, having raised a total of $65.3K across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2019.

When was the latest funding round of Dianox?

Dianox's latest funding was a $***** Seed round on Apr 28, 2021, with participation from 0 investor. Its primary sector is Life Sciences Tech. Globally, the Life Sciences Tech sector has seen $4.57B in funding in 2026 to date.

Where does Dianox rank among its competitors?

Dianox ranks 105th amongst 174 active competitors, of which 69 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Isomorphic Labs, which secured $2.1B in May, 2026.

Who are the top competitors of Dianox?

Dianox's top competitors include Schrodinger, Recursion Pharmaceuticals and XtalPi. Among them, Isomorphic Labs secured the most recent funding round in May, 2026.

Dianox - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of an AI powered drug discovery platform. The platform generate structured nucleic acids for specific protein targets to design drug candidates for a wide range of diseases. It utilizes machine learning to identify potential drug targets and develop aptamers for therapeutic applications. It also offers a range of services aimed at pharmaceutical research and development.

Key Metrics

Founded Year

2019

Location

Copenhagen, Denmark

Stage

Deadpooled

Total Funding

$65.3K in 3 rounds

Latest Funding Round

Seed, Apr 28, 2021, $*****

Last Known Valuation

$***** as on Dec 30, 2020

Investors

R/GA Ventures & 1 more

Ranked

105^th among 174 active competitors

Employee Count

10 as on Apr 30, 2026

Similar Companies

Schrodinger & 203 more

View Dianox's full profile

Dianox is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Dianox ApS CIN: 40559701 , Denmark, Active	Mar 05, 2019	-	1 (As on Nov 30, 2024)

Dianox has raised a total funding of $65.3K over 3 rounds. Its first funding round was on 2019. Dianox has 2 institutional investors.

Here is the list of recent funding rounds of Dianox:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 28, 2021	8464257	Seed	6987142	8029217	3855790	5820884
Dec 30, 2020	6361280	Seed	1259962	5829370	3984254	9318211
2019	6664	Grant (prize money)	2279	5025	7652	Innovationsfonden

Access funding benchmarks and valuations. Sign up today!

View details of Dianox's funding rounds and investors

The founders of Dianox are Christian Code and Huram Konjen.

Here are the details of Dianox's key team members:

Christian Code: Co-Founder & CTO of Dianox.
Huram Konjen: Former Co-Founder & CEO of Dianox.

Dianox's Board of Directors

Dianox's board has 1 active member. Ernie Wilkins Vej is part of team.

Here is the list of Dianox's board of directors:

Name	Type	Representing	Status	Duration
Ernie Wilkins Vej	Team	-	Current	6y 10m

View details of Dianox's Founder profiles and Board Members

Dianox's employee count trend

Dianox has 10 employees as of Apr 26. Here is Dianox's employee count trend over the years:

Uncover Dianox's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Dianox include Schrodinger, Recursion Pharmaceuticals and XtalPi. Here is the list of Top 10 competitors of Dianox, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Schrodinger 1990, New York City (United States), Acquired	Provider of a web-based simulation and modelling tool	$162M	Gates, WuXi AppTec & 16 others	74/100
2nd	Recursion Pharmaceuticals 2013, New York (United States), Public	AI-enabled drug discovery and development platform for novel therapeutics	$452M	Baillie Gifford, Felicis Ventures & 46 others	67/100
3rd	XtalPi 2014, Cambridge (United States), Public	AI-based drug research and development company	$785M	Orbimed, SoftBank Vision Fund & 25 others	67/100
4th	Isomorphic Labs 2021, London (United Kingdom), Series B	Digital platform focused on revolutionizing drug discovery using AI	$2.7B	Thrive Capital, Temasek & 5 others	64/100
5th	Xaira 2023, San Francisco (United States), Series D	AI-enabled platform for drug discovery and development	$1B	Arch Venture Partners, Foresite Labs & 11 others	63/100
6th	METiS Therapeutics 2017, Cambridge (United States), Series B	Provider of an AI-assisted platform for drug discovery and development	$252M	Sequoia Capital China, Luminous Ventures ... & 13 others	63/100
7th	Causaly 2018, London (United Kingdom), Series B	Provider of an AI platform for life sciences and biomedical research	$93M	Index Ventures, EBRD & 14 others	63/100
8th	Gero 2015, Singapore (Singapore), Series A	Developer of reverse engineering technology for controlling aging	$13.5M	Bulba Ventures, Melnichek Investments & 13 others	63/100
9th	Valo Health 2019, Boston (United States), Series B	AI-powered platform for drug discovery and development	$450M	PSP Investments, Koch Disruptive Technologies ... & 7 others	63/100
10th	Tandem AI 2021, New York (United States), Series A	AI-based drug discovery tool for researchers	$82M	Orbimed, Qiming Venture Partners & 4 others	62/100
105th	Dianox 2019, Copenhagen (Denmark), Deadpooled	Provider of an AI powered drug discovery platform	$65.3K	R/GA Ventures, Innovationsfonden	25/100